Primary Record
Dmp 323
- In stock
- 2,470 g
- Purity
- 99.3 %
- CAS
- 151867-81-1
Compound Identifiers & Properties
- CAS
- 151867-81-1
- PubChem CID
- 72404
- SMILES
- C1=CC=C(C=C1)C[C@@H]2[C@@H]([C@H]([C@H](N(C(=O)N2CC3=CC=C(C=C3)CO)CC4=CC=C(C=C4)CO)CC5=CC=CC=C5)O)O
- Canonical SMILES
- O=C1N(Cc2ccc(CO)cc2)[C@H](Cc2ccccc2)[C@H](O)[C@@H](O)[C@@H](Cc2ccccc2)N1Cc1ccc(CO)cc1
Names & Synonyms
- Dmp 323
- Dmp-323
- 1mes
- 1met
- 1meu
- 1qbs
- dmp323
- XM-323
- 151867-81-1
- RefChem:906148
- GlyTouCan:G99916LL
- KXN3869XB2
- D0PB4P
- AC1L2I0G
- UNII-KXN3869XB2
- BDBM150
- CHEMBL21145
- DTXSID40164892
- JCR 424
- JCR-424
- XCVGQMUMMDXKCY-WZJLIZBTSA-N
- orb1703495
- orb1738989
- SCHEMBL2770886
- DTXCID8087383
- CHEBI:42082
- CTK4C7415
- XM 323
- C35H38N2O5
- KST-1A1697
- XM323
- CID72404
- G99916LL
- AR-1A6048
- DM-323
- JCR 424; XM 323
- AKOS040745751
- DMP323(INHIBITOR OF DUPONT MERCK)
- YLMETHYL)]-2H-1,3-DIAZEPINONE
- (4r,5s,6s,7r)-4,7-dibenzyl-5,6-dihydroxy-1,3-bis[4-(hydroxymethyl)benzyl]-1,3-diazepan-2-one
- HY-117747
- J565.493I
- LS-173416
- CS-0067605
- C15662
- (4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-1,3-bis[[4-(hydroxymethyl)phenyl]methyl]-1,3-diazepan-2-one
- 152344-10-0
- Q27120453
- (4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-1,3-bis({[4-(hydroxymethyl)phenyl]methyl})-1,3-diazepan-2-one
- (4R,5S,6S,7R)-4,7-Dibenzyl-5,6-dihydroxy-1,3-bis(4-(hydroxymethyl)benzyl)-1,3-diazepan-2-one
- (4S,5R,6R,7S)-4,7-dibenzyl-5,6-dihydroxy-1,3-bis[[4-(hydroxymethyl)phenyl]methyl]-1,3-diazepan-2-one
- [4-R-(-4-ALPHA,5-ALPHA,6-BETA,7-BETA)]-HEXAHYDRO-5,6-BIS(HYDROXY)-[1,3-BIS([4-HYDROXYMETHYL-PHENYL]METHYL)-4,7-BIS(PHENYLMETHYL)]-2H-1,3-DIAZEPINONE
- 15485-66-2
- 2H-1,3-Diazepin-2-one, hexahydro-5,6-dihydroxy-1,3-bis((4-(hydroxymethyl)phenyl)methyl)-4,7-bis(phenylmethyl)-, (4alpha,5alpha,6beta,7beta)-
- DMP
- Hexahydro-5,6-bis(hydroxy)-1,3-bis((4-(hydroxymethyl)phenyl)methyl)-4,7-bis(phenylmethyl)-2H-1,3-diazepin-2-one
- (4R)-1,3-Bis(4-hydroxymethylbenzyl)-4alpha,7beta-dibenzyl-5alpha,6beta-dihydroxyhexahydro-2H-1,3-diazepine-2-one
- (4R)-1,3-Bis[4-(hydroxymethyl)benzyl]-4alpha,7beta-dibenzyl-5alpha,6beta-dihydroxy-4,5,6,7-tetrahydro-1H-1,3-diazepine-2(3H)-one
- (4R)-1,3-Di[4-(hydroxymethyl)benzyl]-4alpha,7beta-dibenzyl-5alpha,6beta-dihydroxy-4,5,6,7-tetrahydro-1H-1,3-diazepine-2(3H)-one
- (4R)-5alpha,6beta-Dihydroxy-4alpha,7beta-dibenzyl-1,3-bis(4-hydroxymethylbenzyl)hexahydro-2H-1,3-diazepine-2-one
- (4R)-Hexahydro-1,3-bis[4-(hydroxymethyl)benzyl]-4alpha,7beta-dibenzyl-5alpha,6beta-dihydroxy-1H-1,3-diazepine-2-one
- (4R,5S,6S,7R)-4,7-Dibenzyl-5,6-dihydroxy-1,3-bis[4-(hydroxymethyl )benzyl]-1,3-diazepan-2-one
- (4R,5S,6S,7R)-4,7-Dibenzyl-5,6-dihydroxy-1,3-bis{[4-(hydroxymethyl)phenyl]methyl}-1,3-diazepan-2-one
- (4R,5S,6S,7R)-Hexahydro-5,6-dihydroxy-1,3-bis((4-(hydroxymethyl)phenyl)methyl)-4,7-bis(phenylmethyl)-2H-1,3-diazepin-2-one
- (4R-(4A,5A,6B,7B))-HEXAHYDRO-5,6-DIHYDROXY-1,3-BIS((4-(HYDROXYMETHYL)PHENYL)METHYL)-4,7-BIS(PHENYLMETHYL)-2H-1,3-DIAZEPIN-2-ONE
- [4-R-(-4-ALPHA,5-ALPHA,6-BETA,7-BETA)]-HEXAHYDRO-5,6-BIS(HYDROXY)-[1,3-BIS([4-HYDROXYMETHYL-PHENYL]METHYL)-4,7-BIS(PHEN
- [4-R-(-4-ALPHA,5-ALPHA,6-BETA,7-BETA)]-HEXAHYDRO-5,6-BIS(HYDROXY)-[1,3-BIS([4-HYDROXYMETHYL-PHENYL]METHYL)-4,7-BIS(PHEN YLMETHYL)]-2H-1,3-DIAZEPINONE
- [4R-(4.alpha.,5.alpha.,6.beta.,7.beta.)]-Hexahydro-5,6-dihydroxy-1,3-bis[(4-hydroxymethyl)phenyl]methyl]-4,7-bis(phenylmethyl)-2H-1,3-diazepin-2-one
- 1,3-Bis[4-(hydroxymethyl)benzyl]-4alpha,7beta-dibenzyl-5alpha,6beta-dihydroxyhexahydro-1H-1,3-diazepine-2-one
- 2H-1,3-DIAZEPIN-2-ONE, HEXAHYDRO-5,6-DIHYDROXY-1,3-BIS((4-(HYDROXYMETHYL)PHENYL)METHYL)-4,7-BIS(PHENYLMETHYL)-, (4R-(4.ALPHA.,5.ALPHA.,6.BETA.,7.BETA.))-
- CU